Blood glucose pattern management in diabetes: Creating order from disorder

Journal of Diabetes Science and Technology

Volumn 7, Issue 6, 2013, Pages 1575-1584

  Choudhary, Pratik ^a   Genovese, Stefano ^b   Reach, Geŕard ^c,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IRCCS MULTIMEDICA   (Italy)

^c Department of Endocrinology Diabetes and Metabolic Diseases Avicenne Hospital Bobigny   (France)

^d UNIVERSITÉ PARIS 13   (France)

Author keywords

Glycemic variability; Pattern management; Self monitoring of blood glucose; Tools

Indexed keywords

FREESTYLE INSULINX; GLUCOSE; HEMOGLOBIN A1C; SHORT ACTING INSULIN; UNCLASSIFIED DRUG;

AUTOMATED PATTERN RECOGNITION; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; COMPUTER PROGRAM; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INSULIN TREATMENT; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT EDUCATION; REVIEW; SYSTEMATIC REVIEW;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS;

EID: 84900549518     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700618     Document Type: Review

References (47)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-53.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
3. Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes. 1997;46(2):271-86.
4. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-59.
5. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33(6):1389-94.
6. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes. 2008;57(12):3169-76.
7. McCrimmon RJ, Frier BM. Hypoglycaemia, the most feared complication of insulin therapy. Diabete Metab. 1994;20(6):503-12.
8. Thompson CJ, Cummings JF, Chalmers J, Gould C, Newton RW. How have patients reacted to the implications of the DCCT? Diabetes Care. 1996;19(8):876-9.
9. Pickup JC, Kidd J, Burmiston S, Yemane N. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev. 2006;22(3):232-7.
10. Alemzadeh R, Loppnow C, Parton E, Kirby M. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther. 2003;5(2):167-73.
11. Service FJ, O'Brien PC. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia. 2001;44(10):1215-20.
12. Bergenstal RM, Gavin JR 3rd; Global Consensus Conference on Glucose Monitoring Panel. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med. 2005;118(Suppl 9A):1S-6S.
13. Dailey G. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements. Mayo Clin Proc. 2007;82(2):229-36.
14. St John A, Davis WA, Price CP, Davis TM. The value of self-monitoring of blood glucose: a review of recent evidence. J Diabetes Complications. 2010;24(2):129-41.
15. Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R; ATLANTUS Study Group. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care. 2005;28(6):1282-8.
16. Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, Petersen B, Schweitzer M, Wagner RS. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34(2):262-7.
17. Pearson J, Bergenstal R. Fine-tuning control: pattern management versus supplementation. View 1: pattern management: an essential component of effective insulin management. Diabetes Spectr. 2001;14:75-8.
18. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ. 2002;325(7367):746.
19. Sämann A, Mühlhauser I, Bender R, Hunger-Dathe W, Kloos C, Müller UA. Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis. Diabetes Care. 2006;29(10):2196-9.
20. Sämann A, Mühlhauser I, Bender R, Kloos Ch, Müller UA. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia. 2005;48(10):1965-70.
21. Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ. Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care. 1995;18(5):625-30.
22. Choleau C, Albisser AM, Bar-Hen A, Bihan H, Campinos C, Gherbi Z, Jomaa R, Aich M, Cohen R, Reach G. A novel method for assessing insulin dose adjustments by patients with diabetes. J Diabetes Sci Technol. 2007;1(1):3-7.
23. Reach G. Can technology improve adherence to long-term therapies? J Diabetes Sci Technol. 2009;3(3):492-9.
24. Reach G. Patient non-adherence and healthcare-provider inertia are clinical myopia. Diabetes Metab. 2008;34(4 Pt 1):382-5.
25. Reach G. A psychophysical account of patient non-adherence to medical prescriptions. The case of insulin dose adjustment. Diabetes Metab. 2013;39(1):50-5.
26. Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, Axel-Schweitzer M, Petersen B, Wagner RS. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and efective physician interventions: results from the STeP study. Diabetes Technol Ther. 2011;13(8):797-802.
27. Polonsky WH, Jelsovsky Z, Panzera S, Parkin CG, Wagner RS. Primary care physicians identify and act upon glycemic abnormalities found in structured, episodic blood glucose monitoring data from non-insulin-treated type 2 diabetes. Diabetes Technol Ther. 2009;11(5):283-91.
28. Lalic N, Tankova T, Nourredine M, Parkin C, Schweppe U, Amann-Zalan I. Value and utility of structured self-monitoring of blood glucose in real world clinical practice: findings from a multinational observational study. Diabetes Technol Ther. 2012;14(4):338-43.
29. Rodbard HW, Schnell O, Unger J, Rees C, Amstutz L, Parkin CG, Jelsovsky Z, Wegmann N, Axel-Schweitzer M, Wagner RS. Use of an automated decision support tool optimizes clinicians' ability to interpret and appropriately respond to structured self-monitoring of blood glucose data. Diabetes Care. 2012;35(4):693-8.
30. Cox DJ, Gonder-Frederick L, Ritterband L, Clarke W, Kovatchev BP. Prediction of severe hypoglycemia. Diabetes Care. 2007;30(6):1370-3.
31. Kempf K, Kruse J, Martin S. ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2010;12(7):547-53.
32. Hansen MV, Pedersen-Bjergaard U, Heller SR, Wallace TM, Rasmussen AK, Jørgensen HV, Pramming S, Thorsteinsson B. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract. 2009;85(2):183-8.
33. Mazze RS, Shamoon H, Pasmantier R, Lucido D, Murphy J, Hartmann K, Kuykendall V, Lopatin W. Reliability of blood glucose monitoring by patients with diabetes mellitus. Am J Med. 1984;77(2):211-7.
34. Reach G. Two character traits associated with adherence to long term therapies. Diabetes Res Clin Pract. 2012;98(1):19-25.
35. Ainslie G. Précis of breakdown of will. Behav Brain Sci. 2005;28(5):635-73.
36. Reach G. Obstacles to patient education in chronic diseases: a trans-theoretical analysis. Patient Educ Couns. 2009;77(2):192-6.
37. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47(2):263-92.
38. Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185(4157):1124-31.
39. Baumeister RF, Bratslavsky E, Finkenauer C, Vohs KD. Bad is stronger than good. Rev Gen Psychol. 2001;5(4):323-70.
40. Teft G. Lipohypertrophy: patient awareness and implications for practice. J Diabetes Nurs. 2002;6(1):20-3.
41. Rodbard HW, Schnell O, Unger J, Rees C, Amstutz L, Parkin CG, Jelsovsky Z, Wegmann N, Axel-Schweitzer M, Wagner RS. Use of an automated decision support tool optimizes clinicians' ability to interpret and appropriately respond to structured self-monitoring of blood glucose data. Diabetes Care. 2012;35(4):693-8.
42. LifeScan. OneTouch® Verio™Pro. Owner's booklet. http://www.lifescan.co.uk/sites/default/files/pdf/booklets/06687701A-OTVRO-OB- GB-en-zug-R8-Web-new.pdf. Accessed April 2012.
43. Welsh JB, Myers SJ, Uhrinak AN, Kaufman FR, Lee SW. User acceptability and perceived benefits of new reports in CareLink Pro 3.0 Therapy Management Software for Diabetes. J Diabetes Sci Technol. 2012;6(2):481-2.
44. International Diabetes Federation. Guideline. Self-monitoring of blood glucose in non-insulin treated type 2 diabetes. 2009. http://www.idf.org/ webdata/docs/SMBG-EN2.pdf. Accessed April 2012.
45. Klonoff DC, Bergenstal R, Blonde L, Boren SA, Church TS, Gafaney J, Jovanovic L, Kendall DM, Kollman C, Kovatchev BP, Leippert C, Owens DR, Polonsky WH, Reach G, Renard E, Riddell MC, Rubin RR, Schnell O, Siminiero LM, Vigersky RA, Wilson DM, Wollitzer AO. Consensus report of the coalition for clinical research-self-monitoring of blood glucose. J Diabetes Sci Technol. 2008;2(6):1030-53.
46. Parkin CG, Davidson JA. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol. 2009;3(3):500-8.
47. Peel E, Douglas M, Lawton J. Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients' perspectives. BMJ.